TSXV:APC.H - Post by User
Comment by
Goldnboy1on Nov 30, 2020 3:06am
165 Views
Post# 31998577
RE:RE:Nobody seems to be following this deal.
RE:RE:Nobody seems to be following this deal. Ok odds are. My projection for billions. Way too rosie. But here is a realistic vision.
1% gross licence royalty in a $6b annual drug is $60M. The parents are normally 25 years. Competitors can come and improve in your tech. So no for sure thing that you lead market all 25 years.
That being said 4-6 years of gross licensing fees. As a buyout price. Doesn't look bad at all, and it's a drop in the hat for Roche to buy us out for $240-$360m.
This is we were able to license our tech to Roche of their Herceptin drug. Enabling it to achieve new patent protection and bio best market leader status.
I will patiently wait for this next update. Despite the weird insider selling. If somthing material negative was coming. That executive would be in big trouble for selling on negative insider info. Therefore I think it's a false positive and he's just helping introduce small amounts of liquidity in to the market. Perhaps to assist crazy guys like me buying with real world money. lol
This could be a 100x by end of next year if this is what's about to play out!! Pure speculation based on reading the companies entire news history. Hope I'm right.